The US Pharmacopeial Convention (USP) is recalling USP 33?NF 28. The official date for USP 33–NF 28 to go into effect was 1 May 2010. According to a public notice of 12 January 2010, the redesign of ...

Rockville, Md., March 17, 2008 — The U.S. Pharmacopeial (USP) Convention today announced a revised Glycerin monograph in the United States Pharmacopeia (USP), an official compendium of the United ...

USP's Stage 2 heparin monograph revisions address identification, potency, and impurities. In January 2008, the US Centers for Disease Control and Prevention (CDC), along with the Food and Drug ...

Ganeden Biotech is pleased to announce that GanedenBC 30 (Bacillus coagulans GBI-30, 6086) is the first probiotic to have a monograph published in the Food Chemical Codex (FCC) from the U.S.

Rockville, Md., November 15, 2007 — The U.S. Pharmacopeia (USP) is pleased to announce 11 new proposed monographs for dietary supplements for public notice and comment. Six Turmeric-related monographs ...

Metrohm USA is proud to partner with the United States Pharmacopeia (USP) and host a webinar describing the USP monograph modernization program and the impact of this program for analytical ...

RAPS.org needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site such as ...

Utilizing the United States Pharmacopeia and National Formulary (USP-NF) monographs enables pharmaceutical labs and manufacturers to meet strict quality regulations regarding drugs and formulations.

USP@s efforts to develop biological product monographs could impede or delay licensure of biosimilars and other biologics, Janet Woodcock, director of FDA@s Center for Drugs Evaluation and Research, ...